LH Quote, Financials, Valuation and Earnings

Danaher has a net margin of 6.36% compared to Labcorp Holdings's net margin of 16.62%. Labcorp Holdings's return on equity of 9.01% beat Danaher's return on equity of 7.38%.

Labcorp Holdings has a consensus price target of $272.40, signalling upside risk potential of 9.5%. On the other hand Danaher has an analysts' consensus of $247.17 which suggests that it could grow by 26.87%. Given that Danaher has higher upside potential than Labcorp Holdings, analysts believe Danaher is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Danaher has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.561%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.16%. Danaher offers a yield of 0.58% to investors and pays a quarterly dividend of $0.32 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are smaller than Danaher quarterly revenues of $5.7B. Labcorp Holdings's net income of $212.8M is lower than Danaher's net income of $954M. Notably, Labcorp Holdings's price-to-earnings ratio is 28.76x while Danaher's PE ratio is 37.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.59x versus 5.97x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

Exact Sciences has a net margin of 6.36% compared to Labcorp Holdings's net margin of -14.32%. Labcorp Holdings's return on equity of 9.01% beat Exact Sciences's return on equity of -35.57%.

Labcorp Holdings has a consensus price target of $272.40, signalling upside risk potential of 9.5%. On the other hand Exact Sciences has an analysts' consensus of $68.81 which suggests that it could grow by 29.69%. Given that Exact Sciences has higher upside potential than Labcorp Holdings, analysts believe Exact Sciences is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Exact Sciences has a beta of 0.920, suggesting its less volatile than the S&P 500 by 7.968%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.16%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Exact Sciences quarterly revenues of $706.8M. Labcorp Holdings's net income of $212.8M is higher than Exact Sciences's net income of -$101.2M. Notably, Labcorp Holdings's price-to-earnings ratio is 28.76x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.59x versus 3.48x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Illumina has a net margin of 6.36% compared to Labcorp Holdings's net margin of 16.94%. Labcorp Holdings's return on equity of 9.01% beat Illumina's return on equity of -35.09%.

Labcorp Holdings has a consensus price target of $272.40, signalling upside risk potential of 9.5%. On the other hand Illumina has an analysts' consensus of $115.55 which suggests that it could grow by 45.2%. Given that Illumina has higher upside potential than Labcorp Holdings, analysts believe Illumina is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Illumina has a beta of 1.349, suggesting its more volatile than the S&P 500 by 34.945%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.16%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Illumina quarterly revenues of $1.1B. Labcorp Holdings's net income of $212.8M is higher than Illumina's net income of $187M. Notably, Labcorp Holdings's price-to-earnings ratio is 28.76x while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.59x versus 2.90x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

Waters has a net margin of 6.36% compared to Labcorp Holdings's net margin of 18.34%. Labcorp Holdings's return on equity of 9.01% beat Waters's return on equity of 40.75%.

Labcorp Holdings has a consensus price target of $272.40, signalling upside risk potential of 9.5%. On the other hand Waters has an analysts' consensus of $387.19 which suggests that it could grow by 10.35%. Given that Waters has higher upside potential than Labcorp Holdings, analysts believe Waters is more attractive than Labcorp Holdings.

Labcorp Holdings has a beta of 0.826, which suggesting that the stock is 17.43% less volatile than S&P 500. In comparison Waters has a beta of 1.138, suggesting its more volatile than the S&P 500 by 13.849%.

Labcorp Holdings has a quarterly dividend of $0.72 per share corresponding to a yield of 1.16%. Waters offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings pays 32.59% of its earnings as a dividend. Waters pays out -- of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Labcorp Holdings quarterly revenues are $3.3B, which are larger than Waters quarterly revenues of $661.7M. Labcorp Holdings's net income of $212.8M is higher than Waters's net income of $121.4M. Notably, Labcorp Holdings's price-to-earnings ratio is 28.76x while Waters's PE ratio is 31.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings is 1.59x versus 7.01x for Waters. Usually stocks with elevated PS ratios are considered overvalued.